WaveMan · Form 4
Ignelzi Troy A. insider trades
> Search tickers & screens ⌘K
LIVE

Ignelzi Troy A. insider trades

Ignelzi Troy A. has filed 25 Form 4s with the SEC that we hold, for KRTX (Chief Financial Officer), Contineum Therapeutics, Inc. (CTNM) (Director), Rapport Therapeutics, Inc. (RAPP) (Chief Financial Officer) and CINC (Director), among 5 companies in all. Across all of them we count 2 purchases worth $101.0K and 32 sales worth $18.5M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 16,500 shares of KRTX worth $3.8M, dated 2022-08-09. The first filing on our record is dated 2021-08-23 and the latest 2026-06-26.

KRTX

Chief Financial Officer · 15 filings · 32 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-09-08S, sale reported on Form 47,000$813.1K2021-09-10
2021-09-08S, sale reported on Form 4600$72.6K2021-09-10
2021-09-09S, sale reported on Form 4500$60.0K2021-09-10
2021-09-10S, sale reported on Form 41,900$228.1K2021-09-10
2021-11-08S, sale reported on Form 413,500$2.1M2021-11-10
2022-02-15S, sale reported on Form 41,500$166.7K2022-02-17
2022-04-19S, sale reported on Form 43,500$457.8K2022-04-21
2022-04-20S, sale reported on Form 4704$93.8K2022-04-21
2022-04-21S, sale reported on Form 440$5.4K2022-04-21
2022-08-09S, sale reported on Form 416,500$3.8M2022-08-11
2022-09-30S, sale reported on Form 433$7.6K2022-10-04
2022-09-30S, sale reported on Form 45,189$1.2M2022-10-04
2022-09-30S, sale reported on Form 42,819$644.8K2022-10-04
2022-09-30S, sale reported on Form 42,459$558.3K2022-10-04
2022-10-03S, sale reported on Form 42,000$462.6K2022-10-04
2022-10-03S, sale reported on Form 41,000$230.0K2022-10-04
2022-10-03S, sale reported on Form 41,100$255.2K2022-10-04
2022-10-04S, sale reported on Form 4400$93.3K2022-10-04
2022-11-15S, sale reported on Form 416,500$3.7M2022-11-17
2023-01-17S, sale reported on Form 4817$164.6K2023-01-19
2023-01-18S, sale reported on Form 4200$40.0K2023-01-19
2023-02-21S, sale reported on Form 46,000$1.1M2023-02-23
2023-05-23S, sale reported on Form 43,309$738.6K2023-05-25
2023-05-23S, sale reported on Form 41,070$239.9K2023-05-25
2023-05-23S, sale reported on Form 41,022$230.1K2023-05-25
2023-05-23S, sale reported on Form 42,093$465.1K2023-05-25
2023-05-23S, sale reported on Form 4724$160.2K2023-05-25
2023-05-23S, sale reported on Form 4782$176.7K2023-05-25
2023-08-22S, sale reported on Form 480$13.9K2023-08-24
2023-08-22S, sale reported on Form 4855$149.5K2023-08-24
2023-08-22S, sale reported on Form 4505$88.7K2023-08-24
2023-08-22S, sale reported on Form 460$10.6K2023-08-24

Contineum Therapeutics, Inc. (CTNM)

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Rapport Therapeutics, Inc. (RAPP)

Chief Financial Officer · 4 filings · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-03-12P, purchase reported on Form 49,900$100.0K2025-03-13
2025-03-13P, purchase reported on Form 4100$9982025-03-13

CINC

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Harmony Biosciences Holdings, Inc. (HRMY)

Director · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1579829) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms